UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000003044
Receipt number R000002844
Scientific Title Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin-
Date of disclosure of the study information 2010/01/15
Last modified on 2015/01/15 10:47:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin-

Acronym

Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance (EPOCH)

Scientific Title

Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance - Impact on liver function and virological response to Pegylated Interferon alpha-2b/Ribavirin-

Scientific Title:Acronym

Effect of Diet and Exercise Program for Chronic Hepatitis C with Insulin Resistance (EPOCH)

Region

Japan


Condition

Condition

Chronic hepatitis C

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to elucidate whether improvement of insulin resistance through diet and exercise intervention influenced liver function and virological response to pegylated interferon / ribavirin in chronic hepatitis C patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

(1) the degree of improvement in liver function
(2) the virological responce rate

Key secondary outcomes

(1) the degree of improvement in HOMA-IR
(2) the change of body weight and waist circumference


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Behavior,custom

Interventions/Control_1

Patients undergo the following dietary and exercise intervention for more than 3 months.
Diet therapy: Nutritional education by dietitian. Record of diet diary.
Exercise therapy: Instruction based on "exercise guide 2006" publishing by Ministry of Health, Labour and Welfare in Japan. Record of exercise diary.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients satisfying all the below are eligible.
(1)Chronic hepatitis C
(2)HCV genotype 1b or 2 with high viral load (5.0 or >5.0 logIU/mL)
(3)Insulin resistance (HOMA-IR 2 or >2)

Key exclusion criteria

(1)pregnancy, its possibility or lactation
(2)hypersensitivity to IFN, pegylated IFN or ribavirin
(3)uncontrollable cardiac disease
(4)hemoglobinopathy
(5)creatinine clearance less than 50 mL/min
(6)severe mental illnesses such as depression or past history
(7)decompensated liver disease
(8)autoimmune hepatitis
(9)taking medication for DM or poor control of blood glucose levels

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Toshihiko Mizuta

Organization

Saga Medical School

Division name

Department of Internal Medicine

Zip code


Address

5-1-1 Nabeshima, Saga, Japan

TEL

0952-34-2362

Email

mizutat@cc.saga-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Yukie Watanabe

Organization

Saga Medical School

Division name

Division of Hepatology, Diabetology & Endocrinology

Zip code


Address

5-1-1 Nabeshima, Saga, Japan

TEL

0952-34-2362

Homepage URL


Email

watanab2@cc.saga-u.ac.jp


Sponsor or person

Institute

Saga Medical School

Institute

Department

Personal name



Funding Source

Organization

Department of Iinternal Medicine, Saga Medical School

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

佐賀大学医学部附属病院


Other administrative information

Date of disclosure of the study information

2010 Year 01 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2007 Year 06 Month 01 Day

Date of IRB


Anticipated trial start date

2007 Year 06 Month 01 Day

Last follow-up date

2011 Year 03 Month 01 Day

Date of closure to data entry

2011 Year 05 Month 01 Day

Date trial data considered complete

2011 Year 07 Month 01 Day

Date analysis concluded

2011 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 01 Month 15 Day

Last modified on

2015 Year 01 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002844


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name